Cite
Palassin P, Lapierre M, Pyrdziak S, et al. A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors. Cancers (Basel). 2021;13(17)doi: 10.3390/cancers13174449.
Palassin, P., Lapierre, M., Pyrdziak, S., Wagner, A., Stehle, R., Corsini, C., Duffour, J., Bonnet, S., Boulahtouf, A., Rodriguez, C., Ho-Pun-Cheung, A., Lopez-Crapez, E., Boissière-Michot, F., Bibeau, F., Thezenas, S., Elarouci, N., Selves, J., Hoffmann, J. S., Roepman, P., Mazard, T., Buhard, O., Duval, A., Jalaguier, S., Cavaillès, V., & Castet-Nicolas, A. (2021). A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors. Cancers, 13(17), . https://doi.org/10.3390/cancers13174449
Palassin, Pascale, et al. "A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors." Cancers vol. 13,17 (2021). doi: https://doi.org/10.3390/cancers13174449
Palassin P, Lapierre M, Pyrdziak S, Wagner A, Stehle R, Corsini C, Duffour J, Bonnet S, Boulahtouf A, Rodriguez C, Ho-Pun-Cheung A, Lopez-Crapez E, Boissière-Michot F, Bibeau F, Thezenas S, Elarouci N, Selves J, Hoffmann JS, Roepman P, Mazard T, Buhard O, Duval A, Jalaguier S, Cavaillès V, Castet-Nicolas A. A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors. Cancers (Basel). 2021 Sep 03;13(17). doi: 10.3390/cancers13174449. PMID: 34503257; PMCID: PMC8430632.
Copy
Download .nbib